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ABSTRACT The small GTPase RhoA plays a crucial role in the different stages of cytokinesis, 
including contractile ring formation, cleavage furrow ingression, and midbody abscission. 
Citron kinase (CIT-K), a protein required for cytokinesis and conserved from insects to mam-
mals, is currently considered a cytokinesis-specific effector of active RhoA. In agreement with 
previous observations, we show here that, as in Drosophila cells, CIT-K is specifically required 
for abscission in mammalian cells. However, in contrast with the current view, we provide 
evidence that CIT-K is an upstream regulator rather than a downstream effector of RhoA dur-
ing late cytokinesis. In addition, we show that CIT-K is capable of physically and functionally 
interacting with the actin-binding protein anillin. Active RhoA and anillin are displaced from 
the midbody in CIT-K-depleted cells, while only anillin, but not CIT-K, is affected if RhoA is 
inactivated in late cytokinesis. The overexpression of CIT-K and of anillin leads to abscission 
delay. However, the delay produced by CIT-K overexpression can be reversed by RhoA inac-
tivation, while the delay produced by anillin overexpression is RhoA-independent. Altogeth-
er, these results indicate that CIT-K is a crucial abscission regulator that may promote mid-
body stability through active RhoA and anillin.
INTRODUCTION
Cytokinesis is the final stage of the cell division cycle that physi-
cally separates the two daughter cells at the end of mitosis (Glotzer, 
2005; Barr and Gruneberg, 2007). During anaphase, positional 
cues emanating from the central spindle and/or from astral micro-
tubules drive the assembly of an equatorial ring of actin and myo-
sin that constricts and furrows the plasma membrane (Barr and 
Gruneberg, 2007; Pollard, 2010). When the cleavage furrow meets 
the central spindle, the two daughter cells remain connected by a 
cytoplasmic bridge that contains the midbody, a specialized struc-
ture formed at the interdigitating plus ends of central spindle mi-
crotubules (Glotzer, 2005; Barr and Gruneberg, 2007). Finally, the 
midbody is resolved by an active process known as abscission, 
which requires the dismantling of actin filaments and specific 
membrane trafficking events (Barr and Gruneberg, 2007; Schiel 
and Prekeris, 2010). The tetraploid state that results from cytokine-
sis failure can lead to chromosomal instability and tumorigenesis 
(Fujiwara et al., 2005; Caldwell et al., 2007; Li et al., 2010; Sagona 
and Stenmark, 2010). The small GTPase RhoA is a master compo-
nent of cytokinesis control mechanisms and plays essential roles in 
cytokinesis throughout eukaryotes (Piekny et al., 2005). In animal 
cells, active RhoA is absolutely required for the initial stages of 
cytokinesis, promoting formation and stabilization of the cleavage 
furrow through the control of actin polymerization (Piekny et al., 
2005). In addition, it is also essential for driving contraction of the 
actin ring, through the stimulation of myosin light chain (MLC) 
phosphorylation (Werner and Glotzer, 2008). In contrast, once the 
midbody has formed, RhoA must be inactivated, since an excess 
of active RhoA may inhibit abscission (Morin et al., 2009). Thus, to 
ensure the orderly progression of cytokinesis until the final cut, 
animal cells must tightly control in time and space the cortical 
Monitoring Editor
Kozo Kaibuchi
Nagoya University
Received: Dec 8, 2010
Revised: Aug 4, 2011
Accepted: Aug 9, 2011
 http://www.molbiolcell.org/content/suppl/2011/08/13/mbc.E10-12-0952.DC1.html
Supplemental Material can be found at: 
Volume 22 October 15, 2011 CIT-K regulates abscission through RhoA | 3769 
localization of RhoA and its activation state, which impinges on the 
activity of several effector proteins (Piekny et al., 2005).
The scaffold protein anillin (Field and Alberts, 1995; Oegema et al., 
2000) is one of the most crucial partners of RhoA during cytokinesis 
and plays a fundamental role in the assembly and stabilization of the 
contractile ring by interacting with RhoA, septins, F-actin, myosin II, 
and mDia2 (Kinoshita et al., 2002; Straight et al., 2005; Hickson and 
O’Farrell, 2008; Piekny and Glotzer, 2008; Watanabe et al., 2010). 
During anaphase, anillin is recruited to the equatorial cortex (D’Avino 
et al., 2008) by at least two RhoA-dependent mechanisms (Hickson 
and O’Farrell, 2008) involving an interaction with F-actin or with the 
plus ends of microtubules, respectively. Anillin depletion results in 
cleavage furrow instability, leading to characteristic cytoplasmic os-
cillations and preventing midbody formation (Straight et al., 2005; 
Zhao and Fang, 2005). In addition to this early function, a late role for 
anillin in cytokinesis has been proposed. Indeed, in Drosophila S2 
cells, anillin depletion leads to a late phenotype characterized by 
excessive membrane blebbing around the midbody and abscission 
failure (Somma et al., 2002). However, this possibility has not been 
confirmed so far in mammalian cells, due to the strong early pheno-
type caused by anillin inactivation in this 
context (Hickson and O’Farrell, 2008; Piekny 
and Glotzer, 2008). Interestingly, the anillin 
phenotype observed in anillin-depleted 
Drosophila cells is very similar to the pheno-
type caused by depletion of citron kinase 
(CIT-K; Naim et al., 2004), a conserved cy-
tokinesis protein that binds active-RhoA (Di 
Cunto et al., 1998; Madaule et al., 1998). In 
mammalian cells, CIT-K localizes at the cleav-
age furrow through a RhoA-dependent 
mechanism (Eda et al., 2001) and concen-
trates in the midbody at later stages. Studies 
in CIT-K knockout mice (Di Cunto et al., 
2000) and rats (Liu et al., 2003) would indi-
cate that, in vivo, the protein is absolutely 
required for cytokinesis only in specific cell 
types. However, studies performed in HeLa 
cells by overexpressing CIT-K mutants 
(Madaule et al., 1998) or by RNA interfer-
ence (RNAi)-based knockdown (Gruneberg 
et al., 2006) are consistent with a more gen-
eral role for CIT-K in mammalian cytokinesis. 
It was initially proposed that mammalian CIT-
K may act during cleavage furrow ingression, 
regulating the levels of di-phosphorylated 
MLC downstream of RhoA (Eda et al., 2001; 
Yamashiro et al., 2003; Matsumura, 2005). 
However, more recent observations suggest 
that, even in mammals, CIT-K could be spe-
cifically involved in the latest stages of cytoki-
nesis (Gruneberg et al., 2006; Neumann 
et al., 2010). The similarity of their RNAi phe-
notypes in Drosophila cells suggested that 
CIT-K and anillin could functionally interact 
(Naim et al., 2004), but this possibility has 
not yet been investigated. In addition, al-
though it is still commonly believed that CIT-
K is a RhoA effector, studies performed in 
both Drosophila (Dean and Spudich, 2006) 
and mammalian cells (Matsumura, 2005) in-
dicate that it has little or no role in regulating 
MLC phosphorylation in vivo.
In this report, we address in more detail the dynamics of cytoki-
nesis failure in CIT-K-depleted or overexpressing mammalian cells. 
Moreover, we set out to analyze the functional relationships among 
CIT-K, RhoA, and anillin in late cytokinesis of HeLa cells.
RESULTS
Appropriate levels of CIT-K are necessary for abscission
CIT-K has been shown to be involved in cytokinesis control on the 
basis of both in vitro (Madaule et al., 1998; Naim et al., 2004; 
Gruneberg et al., 2006) and in vivo (Di Cunto et al., 2000; D’Avino 
et al., 2004; Naim et al., 2004) evidence. However, the previous 
studies did not directly clarify when CIT-K is required during mam-
malian cell cytokinesis and by which mechanisms it may act. To start 
resolving these issues, we analyzed cell division in HeLa cells de-
pleted of endogenous CIT-K, using a previously described small 
interfering RNA (siRNA) sequence (Gruneberg et al., 2006). CIT-K is 
efficiently depleted 48 h after transfection (Figure 1A). As expected, 
CIT-K depletion significantly increased the formation of multinucle-
ated cells (37.12% ± 1.51%) compared with cells transfected with 
FIGURE 1: CIT-K is require for abscission both in vitro and in vivo. (A) Selected frames from 
time-lapse series of HeLa cells undergoing cytokinesis. HeLa cells were transfected with control 
or CIT-K siRNA and observed 30 h posttransfection by time-lapse video microscopy. Top, A 
control cytokinesis. CIT-K-depleted cells displayed an “early fusion” (middle) and a “late fusion” 
(bottom) phenotype. At least 50 cells in cytokinesis were analyzed for each condition. For full 
movies, see Movies S1–S3. The level of endogenous CIT-K and RhoA expression in whole-cell 
lysates was determined by immunoblotting using the corresponding antibodies. Tubulin was the 
internal loading control (right). (B) Selected frames from time-lapse series of GPCs undergoing 
cytokinesis. GPCs were isolated from P5 wild-type (WT) and CIT-K knockout (CIT-K−/−) mice and 
observed by time-lapse video microscopy 3 h after plating. At least 40 cells in cytokinesis were 
analyzed for CIT-K−/− mice. For full movies, see Movies S6 and S7.
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control siRNA (5.51% ± 0.79%). To assess which stages of cytokinesis 
are affected by CIT-K depletion, we observed cells 30 h posttrans-
fection using time-lapse video microscopy. In all CIT-K-depleted 
cells, nuclear division, cleavage furrow formation, cleavage furrow 
ingression, and midbody formation were indistinguishable from 
controls (Figure 1A and Supplemental Movies S1–S3). However, the 
majority of CIT-K-depleted cells were unable to complete cytokine-
sis. In particular, we observed two distinct abscission phenotypes, 
which will be referred to as “early fusion” and “late fusion. In early 
fusion (Figure 1A and Movie S2), soon after cleavage furrow ingres-
sion and midbody formation, the two daughter cells exhibit exces-
sive cortical blebbing, after which the midbody regresses, leading 
to binucleated cells. In late fusion (Figure 1A and Movie S3), after 
midbody formation, cells do not exhibit membrane instabilities, re-
attach normally, and remain interconnected by a cytoplasmic bridge 
for an interval comparable to the interval observed in control cells. 
However, cells subsequently fail to undergo abscission and fuse 
back together, resulting in the formation of binucleated cells. Similar 
results (Supplemental Figure S1A and Movies S4 and S5) were ob-
tained by using, instead of siRNAs, a previously published small 
hairpin RNA (shRNA)-expressing construct (Camera et al., 2008). To 
further confirm the specificity of the phenotype detected in HeLa 
cells, and to address whether it is relevant to the in vivo phenotype 
that we have previously described (Di Cunto et al., 2000), we ana-
lyzed the mitosis of cerebellar granule precursor cells (GPC) in pri-
mary culture using time-lapse video microscopy. We chose these 
cells because they are extremely sensitive to the absence of CIT-K 
(Di Cunto et al., 2000). GPC prepared from control postnatal day 
5 mouse cerebella divided normally under our culture conditions 
(Figure 1B and Movie S6). In contrast, most of the GPC prepared 
from littermate CIT-K−/− mice failed cytokinesis, with kinetics and 
morphology very similar to those observed in CIT-K-depleted HeLa 
cells (Figure 1B and Movie S7).
These results indicate that, even in mam-
malian cells, CIT-K is required for midbody 
abscission, but not for the earlier cytokinesis 
events.
To further understand the function of CIT-
K during cytokinesis, we analyzed the effects 
of CIT-K overexpression on cell division. 
HeLa cells were transfected with a plasmid 
encoding a fusion between CIT-K and Cherry 
fluorescent protein (CIT-K-Cherry), or with 
Cherry alone. As previously described for 
the other tagged version of CIT-K (Eda 
et al., 2001), the overexpressed CIT-K-
Cherry protein accumulated during inter-
phase in characteristic cytoplasmic dots, 
which were dispersed during metaphase. 
Afterward, CIT-K-Cherry daccumulated at 
the cleavage furrow and at the midbody 
(Figure S2 and Movie S8). Interestingly, 
CIT-K-Cherry overexpression led to a four-
fold increase in the frequency of multinucle-
ated cells citron kinase active (CKA)-Cherry 
38.08% ± 10.15%; Cherry 10.85% ± 6.38%; 
p = 0017). As seen by time-lapse video mi-
croscopy, ∼35% of the overexpressing cells 
that initiate mitosis fail to complete cytoki-
nesis. In these cells, anaphase and cytokine-
sis initiation was normal. However, after 
cleavage furrow ingression, the cytosol and 
the DNA of the two daughter cells underwent rapid oscillatory 
movements, followed by cleavage furrow regression and formation 
of binucleated cells (Figure 2 and Movie S9). It must be noted that 
this phenotype, which was previously detected after the expression 
of mutant forms of CIT-K (Madaule et al., 1998), is strongly reminis-
cent of the phenotype displayed by anillin-depleted cells (Straight 
et al., 2005; Zhao and Fang, 2005). In the remaining CIT-K-overex-
pressing cells, push–pull movements were not detectable, and cy-
tokinesis progressed normally to the midbody stage. However, these 
cells took a very long time to divide and, in some cases, did not 
separate at all within the period of observation (10–12 h; Figure 2 
and Movie S10). We measured the time from anaphase to abscission 
of each cell division: the abscission time of CIT-K-overexpressing 
cells is almost double the time observed in control cells (Figure 2).
Altogether, our knockdown and overexpression experiments 
confirm that, even in mammalian cells, the main role of CIT-K is to 
regulate abscission.
CIT-K is required to maintain anillin and RhoA 
at the midbody
To establish how CIT-K regulates abscission, we hypothesized that 
it may affect the localization of critical cytokinesis components. 
Therefore, we studied the localization of central spindle proteins 
(RACGAP1, ECT2, Aurora B) and of cleavage furrow proteins (actin, 
myosin IIB, anillin, and RhoA) in CIT-K-depleted cells 30 h after 
transfection. In particular, we concentrated on two cytokinesis 
stages: early midbody, when the midbody is formed but cells are 
round and have condensed DNA, and late midbody, when the nu-
clei are re-formed and the two daughter cells have already spread, 
but are still linked by the cytoplasmic bridge. Actin, myosin IIB, 
ECT2, RACGAP1, and Aurora B display the expected localizations 
in both control and CIT-K-depleted cells (Figure S3A). Interestingly, 
in the cases of RACGAP1 and Aurora B, we did not observe 
FIGURE 2: Appropriate levels of CIT-K are necessary for abscission. (A) Selected frames from 
time-lapse series of HeLa cells transfected with either Cherry or CIT-K-Cherry, using the same 
conditions as in Figure 1. Insets in the first frames represent red fluorescence of the imaged 
cells. During cytokinesis, CIT-K overexpression leads to both oscillatory movements (top) and 
delayed abscission (bottom). For full movies, see Movies S9 and S10. (B) Quantification of 
abscission time of HeLa cells expressing either Cherry or CIT-K-Cherry and not undergoing 
oscillatory movements during the time-lapse analysis. A total of 30 CIT-K-Cherry and 42 control 
cells were scored. Error bars represent SEM. Asterisks indicate that the difference is statistically 
significant using Student’s t test (p < 0.01).
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significant differences, even with phosphospecific antibodies rec-
ognizing, respectively, S387 and T232 (Figure S3A), two Aurora B 
target sites that play a major role in cytokinesis (Minoshima et al., 
2003; Yasui et al., 2004). In contrast, the 
localization of anillin was strongly affected. 
In control cells, anillin concentrated at the 
cleavage furrow upon anaphase onset and 
localized prominently to the midbody-sur-
rounding cortex in cytokinesis. At later 
stages, anillin localized in clusters along the 
cytoplasmic bridge (Figure 3A). Conversely, 
in CIT-K-depleted cells, after accumulating 
normally at the cleavage furrow, anillin dis-
played an abnormal distribution. Indeed, at 
the early midbody stage, CIT-K depletion 
led to a dramatic increase of cells showing 
an extended anillin signal in the midbody 
(68% ± 6.75%), compared with the control 
cells (18.64% ± 2.72%; Figure 3A). Even 
more strikingly, at the late midbody stage, 
anillin was completely lost from the cyto-
plasmic bridge in 67.18% of CIT-K-depleted 
cells (Figure 3A). Quite unexpectedly, we 
even observed a similar delocalization phe-
notype for the active pool of RhoA, revealed 
by a trichloroacetic acid (TCA)-fixation pro-
tocol (Yonemura et al., 2004). In control 
cells, active RhoA localized exclusively at 
the midbody (Figure 3B). In contrast, in 
∼50% of early midbody cells depleted of 
CIT-K, although active RhoA was clearly ac-
cumulated at the midzone, it formed an 
asymmetrical and much-less-focused band, 
and was clearly detectable at the cell cortex, 
outside the midzone (Figure 3B). At later 
stages, RhoA became completely undetect-
able in ∼85% of CIT-K-depleted cells (Figure 
3B). Similar results were obtained using a 
previously published shRNA-expressing 
construct instead of siRNAs (Camera et al., 
2008; Figure S1, B and C).
These results suggest that, during late 
cytokinesis, CIT-K may stabilize the midbody 
by promoting the fixation of anillin and of 
active RhoA.
RhoA activity is required in late 
cytokinesis for anillin localization 
but not for CIT-K localization
The delocalization of RhoA and anillin in 
CIT-K-depleted cells may indicate that CIT-K 
retains RhoA and anillin at the midbody, or 
that these proteins can be interdependent 
during late cytokinesis. To discriminate 
between these possibilities, we specifically 
inactivated RhoA in late cytokinesis, treat-
ing synchronized HeLa cells with a cell-per-
meable Clostridium botulinum C3-toxin 
(Winton et al., 2002). In particular, HeLa cells 
were synchronized with the thymidine/no-
codazole method and were treated with C3 
90 min after nocodazole release (Figure 3C). 
Parallel immunofluorescence analysis indicated that, after this treat-
ment, the majority of cells had passed through mitosis and were in 
cytokinesis (unpublished data). As expected, C3 treatment strongly 
FIGURE 3: CIT-K is required to maintain anillin and RhoA at the midbody, whereas RhoA activity 
is required for anillin but not for CIT-K localization. (A and B) Asynchronous HeLa cells were 
transfected with control or CIT-K siRNA and analyzed by immunofluorescence 30 h 
posttransfection. The localization of (A) anillin (ANLN) and (B) active RhoA was determined in 
cells in early and in late cytokinesis. Anti–α-tubulin antibodies (Tub) and DAPI were used to 
reveal midbodies and nuclei, respectively. At least 100 cells in cytokinesis in three independent 
experiments were scored. (C) HeLa cells, blocked at prometaphase with thymidine and 
nocodazole, were released into fresh medium for 90 min to allow them to progress through 
mitosis and cytokinesis. Cells were then treated with solvent alone (CTRL) or with a cell-
permeable C3 transferase (2 μg/ml) for 1 h and processed for immunofluorescence. 
Immunofluorescence of late cytokinesis figures revealed the midbody localization of anillin and 
CIT-K. Cells were counterstained for α-tubulin (Tub) and DAPI to reveal midbodies and nuclei, 
respectively. At least 150 cells in cytokinesis in four independent experiments were scored.
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decreased the number of late midbody cells in which RhoA could be 
detected at the midbody (39.25% ± 0.12% vs. 86.99% ± 0.06% in 
the control cells, unpublished data). Moreover, C3 treatment strongly 
affected the localization of anillin (Figure 3C). In particular, anillin 
could not be detected in the majority of C3-treated late cytokinesis 
cells (54.22% ± 0.18% vs. 16.94% ± 0.13% in control cells).
Strikingly, a CIT-K signal indistinguishable from the signal ob-
served in control cells was detected in all the late cytokinesis we 
analyzed (Figure 3C), thus indicating that the disappearance of ac-
tive RhoA from the midbody has no effect on CIT-K localization at 
this stage. These data indicate that, in late 
cytokinesis, CIT-K is necessary to retain at 
the midbody both RhoA and anillin, while 
active RhoA is necessary only to retain anil-
lin. Due to the penetrant early phenotype 
elicited by anillin depletion, we could not 
evaluate whether anillin might be required 
for CIT-K and RhoA localization in late 
cytokinesis.
CIT-K forms a physical complex 
with anillin
The results presented in the preceding sec-
tion, together with the previous suggestion 
of a possible functional interaction between 
CIT-K and anillin (Naim et al., 2004), 
prompted us to ask whether the two pro-
teins may physically interact in dividing cells. 
Moreover, we wanted to address whether 
an eventual interaction could be modulated 
during the cell cycle. To this end, HeLa cells 
were synchronized at the G1/S boundary by 
a thymidine block, released into fresh me-
dia, and harvested hourly. The time window 
for mitosis was identified by the levels of cy-
clin B. As expected (Liu et al., 2003; Zhao 
and Fang, 2005), Western blot analysis indi-
cated that levels of CIT-K and anillin are 
regulated throughout the cell cycle, peaking 
in mitosis and dropping at G1. A reciprocal 
coimmunoprecipitation of the two endoge-
nous proteins was detected throughout mi-
tosis. The association was particularly obvi-
ous 11 h after release, that is, when levels of 
cyclin B decreased and cells exited mitosis 
(Figure 4A).
To determine which anillin domains are 
involved in the interaction with CIT-K, we 
tested several green fluorescent protein 
(GFP)–anillin constructs for their ability to 
bind cotransfected CIT-K. Interestingly, we 
found that the interaction was strongly de-
creased by deletion of the first 100 amino 
acids of anillin (Figure 4B), which contain the 
nuclear localization signal (NLS). Moreover, 
the interaction was completely lost with a 
construct in which the whole anillin N-termi-
nal region, including not only the NLS but 
also the myosin- and the actin-binding do-
mains, was deleted. Conversely, we found 
that the N-terminal region is the minimal 
portion of anillin sufficient for binding to 
CIT-K (Figure 4B). Similar experiments, performed with wild-type an-
illin and CIT-K mutants, revealed that the N-terminal half of CIT-K 
(containing the kinase domain and the coiled-coil region) is not ca-
pable of interacting with anillin. Instead, we found a strong associa-
tion between anillin and the C-terminal portion of CIT-K, which 
contains several protein–protein interaction domains. However, 
constructs lacking either the Rho-binding domain, the Citron, MRCK, 
Genegis-Khan homology domain (CMG) domain (CMG), the pro-
line-rich, putative SH3-binding domain (SH3B), and the PDZ-binding 
domain (PDZB), or the zinc finger (ZF) and pleckstrin homology (PH) 
FIGURE 4: CIT-K forms a physical complex with anillin. (A) HeLa cells were synchronized at the 
G1/S boundary by a thymidine block, released into fresh media, and harvested every hour. Left, 
Total cell extracts from asynchronous cells (asy) or from the indicated time points were analyzed 
by Western blotting to monitor the amount of CIT-K and anillin around the time of mitosis exit 
(corresponding to 11 h, as shown by cyclincyclin B decrease). Vinculin was used as internal 
loading control. Right, Total extracts from the indicated time points were immunoprecipitated 
with anti-CIT-K or anti-anillin antibodies. Western blotting with the indicated antibodies revealed 
reciprocal coimmunoprecipitation of the endogenous proteins. (B) The indicated GFP-anillin 
fusion constructs were cotransfected with Myc-tagged CITK-expression plasmid in HEK293T for 
48 h. Immunoprecipitations were then performed from total cell lysates using anti-GFP antibody, 
and Western blotting was used to reveal the immunoprecipitated proteins for the GFP and Myc 
epitopes. Conserved regions and previously described domains are indicated: *, 2 × NLS 
sequences; My, myosin-binding domain (aa 146–258); Ac, actin-binding and -bundling region 
(aa 258–371); AHD, anillin homology domain (aa 608–943); PH domain (aa 943–1087). (C) The 
indicated Myc-CIT-K fusion constructs were cotransfected with GFP-anillin, as in (B). 
Immunoprecipitations and Western blotting were performed as in (B). Conserved regions and 
previously described domains are indicated: KD, Ser/Thr kinase domain; Coiled-coil, coiled-coil 
region; RhoBD, Rho-binding domain; ZF domain; PH domain; CMG; SH3B domain; PDZB 
domain. In every case, the results shown are representative examples of at least three different 
experiments.
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domains, were still able to bind to anillin (Figure 4C). Therefore an 
extensive C-terminal region of CIT-K and the N-terminal region of 
anillin are responsible for their interaction.
CIT-K overexpression affects the localization of anillin 
and of active RhoA
Considering that the knockdown of CIT-K impairs the retention of 
anillin and of active RhoA at the midbody and that CIT-K may form 
a physical complex with both proteins, a simple explanation for the 
overexpression phenotypes we observed could be that high levels 
of CIT-K may dominantly interfere with localization of anillin and 
RhoA. To address this possibility, we first studied the localization of 
endogenous anillin and of active RhoA in CIT-K-overexpressing 
cells. Interestingly, in interphase cells, both molecules were strongly 
recruited to the characteristic CIT-K clusters (Figure 5A). In particular, 
while anillin showed a diffuse nuclear localization in control cells, in 
CIT-K-overexpressing cells, the nucleus was mostly negative and the 
anillin signal was detected in the CIT-K dots, which in the majority of 
cases resided in the cytoplasm (Figure 5A). On the other hand, not 
only was the acid-fixable pool of RhoA concentrated in the CIT-K 
clusters, but the overall intensity of its signal was strongly increased 
in the CIT-K-overexpressing cells (Figure 5A). These results indicate 
CIT-K can efficiently recruit both anillin and RhoA, and it can stabilize 
RhoA in an acid-fixable form. To address whether CIT-K overexpres-
sion may alter the localization of anillin and RhoA during cytokinesis, 
we used dynamic fluorescence microscopy to analyze HeLa cells 
cotransfected with CIT-K-Cherry and with either GFP-anillin or 
Caenorhabditis elegans (ce) GFP-RhoA. 
The localization of the latter protein in divid-
ing mammalian cells faithfully represents 
the localization of endogenous active RhoA 
(Yuce et al., 2005). As in the case of the en-
dogenous proteins, overexpressed GFP-an-
illin and GFP-RhoA accumulated in the CIT-
K clusters during interphase. Moreover, 
when the cells started to round up at the 
beginning of mitosis, the clusters of overex-
pressed proteins were almost completely 
disassembled (Figures 5B and S4 and Mov-
ies S11 and S12). In cells that underwent 
oscillatory movements, CIT-K-Cherry dis-
played an asymmetrical distribution from 
the beginning of mitosis, with prominent 
crescents already being detectable at the 
metaphase stage (Figure 6B and Movie 
S11). Interestingly, in these cells, GFP-anillin 
displayed essentially the same localization 
of CIT-K-Cherry throughout mitosis (Figure 
S4 and Movie S12), while GFP-RhoA be-
haved differently at the earliest stages. In-
deed, GFP-RhoA showed a diffuse localiza-
tion during metaphase and started to enrich 
at the midzone during anaphase. However, 
when cells started to oscillate, even GFP-
RhoA became colocalized with the CIT-K 
asymmetrical enrichments (Figure 6B and 
Movie S11).
On the other hand, in the cotransfected 
cells that formed a midbody, CIT-K overex-
pression did not dramatically change the 
distribution of GFP-anillin and of GFP-RhoA 
throughout mitosis and cytokinesis. Never-
theless, in analyzing the localization of the endogenous proteins 
during late cytokinesis, we observed that CIT-K overexpression in-
duced a stronger and broader accumulation of RhoA-GTP at the 
midbody (Figure 5C).
These data show that CIT-K overexpression is able to perturb 
anillin and RhoA localization not only during cytokinesis but also 
during interphase. Moreover, they suggest that CIT-K overexpres-
sion could cause abscission delay through a prolonged accumula-
tion of active RhoA at the midbody.
Functional interaction between CIT-K, anillin,  
and RhoA in late cytokinesis
The data presented in the preceding section strongly suggest that 
CIT-K, RhoA, and anillin stabilize the midbody in late cytokinesis, 
with CIT-K and anillin working upstream and downstream of RhoA, 
respectively. To test this model, we treated late cytokinesis cells 
overexpressing CIT-K or anillin with a cell-permeable C3 toxin and 
evaluated their kinetic of cytokinesis exit. As expected, under basal 
conditions, the percentage of cytokinesis was significantly increased 
by CIT-K-Cherry overexpression 180 min after nocodazole release 
(Figure 6A). Interestingly, the carboxy-terminal region of CIT-K, 
which localizes to the midbody (Figure S5A), was even more effec-
tive than the wild-type protein in this assay (Figure S5B). Impor-
tantly, the overexpression of GFP-anillin results in a similar abscis-
sion delay (Figure 6B), thus confirming that anillin may play a role in 
late cytokinesis. However, C3-toxin treatment revealed that the de-
lay induced by CIT-K and by its C-terminal region are sensitive to 
FIGURE 5: CIT-K overexpression affects the localization of anillin and of active RhoA. 
(A) HeLa cells were transfected with either Cherry or Cherry-CIT-K. Interphase cells were 
analyzed by immunofluorescence for localization of the endogenous anillin or active RhoA. 
(B) Selected frames from time-lapse series of HeLa cells undergoing cytokinesis. HeLa cells 
were cotransfected with GFP-ceRhoA and CIT-K-Cherry and observed 30 h posttransfection 
by time-lapse video microscopy. For full movie, see Movie S11. (C) HeLa cells in late 
cytokinesis, expressing either Cherry or CIT-K-Cherry, were analyzed for the localization of 
active RhoA by immunofluorescence 30 h posttransfection. Nuclei were counterstained 
with DAPI.
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RhoA inactivation (Figures 6A and S5B), while the anillin-induced 
delay is independent from RhoA activity (Figure 6B). To address 
whether the interaction between CIT-K and anillin is functionally rel-
evant, we investigated the role of the N-terminal domain of anillin. 
Overexpression of this domain fused to GFP had no dominant ef-
fects on cytokinesis, presumably because the protein is rapidly con-
centrated into the nucleus and does not localize to the midbody 
after anaphase (Figure S5C). Conversely, compared with wild-type 
anillin, the Δ-NLS anillin mutant, which has a strongly reduced CIT-K-
binding ability (Figure 4C), still localized to the midbody, although it 
also showed a diffuse cytoplasmic localization (Figure S5C). Inter-
estingly, although this mutant can rescue the early phenotype in-
duced by anillin depletion (Piekny and Glotzer, 2008), its overex-
pression had no effect on cytokinesis exit, either under basal 
conditions or upon C3 treatment (Figure 6B). Altogether, these re-
sults strongly suggest that CIT-K could stabilize anillin at the mid-
body both through RhoA and through a physical interaction with 
the anillin N-terminal region.
CIT-K regulates the activation state of RhoA  
in late cytokinesis
Although CIT-K is commonly considered a downstream effector of 
RhoA, the phenotypes we have observed with CIT-K depletion and 
overexpression would be rather consistent with the idea that it may 
regulate RhoA activity at the midbody. To address this hypothesis, 
we measured the levels of GTP-RhoA in synchronized HeLa cells in 
which CIT-K was either down-regulated or overexpressed. More pre-
cisely, we measured the levels of active RhoA 180 min after nocoda-
zole release, because at this time most cells were in late cytokinesis. 
Importantly, as shown in Figure 7A, active RhoA was significantly re-
duced in cells depleted of CIT-K. Conversely, overexpressed wild-
type CIT-K and CIT-K C-terminal region significantly increased the 
levels of active RhoA (Figure 7B). Interestingly, the RhoA-binding do-
main was necessary for RhoA stimulation in the latter assay; neither 
the N-terminal region of CIT-K nor a mutant deleted of the Rho-bind-
ing domain elicited significant changes. Finally, we addressed 
whether CIT-K could modulate the levels of GTP-RhoA through the 
stimulation of a guanine nucleotide exchange factor (GEF) activity or 
through the inhibition of a GAP activity. To this end, we measured the 
total Rho-GEF and the total Rho-GAP activities of lysates obtained 
from cells in late cytokinesis after treatment with control or with CIT-K 
siRNAs. As shown in Figure 7C, CIT-K depletion dproduced a signifi-
cant decrease of the total Rho-GEF activity. Moreover, Figure 7D 
shows that CIT-K RNAi even produced a significant decrease in the 
total RhoGAP activity. Despite these differences, we did not detect 
significant changes in the total levels of the GEFs and GAPs known 
to play a role in cytokinesis, such as ECT2 (Yuce et al., 2005), GEF-H1 
and its activated form (pS885; Birkenfeld et al., 2007), p190RhoGAP 
(Mikawa et al., 2008), and RACGAP1 and its activated form (pS387; 
Minoshima et al., 2003; Figure S3B). Moreover, in the cases we could 
evaluate with the reagents available, we did not detect significant 
changes in their localization to the midbody (Figure S3A). The impli-
cations of these results are discussed in the following section.
DISCUSSION
In this report, we have provided conclusive evidence that, even in 
mammalian cells, the main role of CIT-K in cytokinesis is to regulate 
abscission. Indeed, our dynamic microscopy analysis has shown 
that CIT-K knockdown has no detectable effects on cleavage fur-
row formation, on cleavage furrow ingression, and on midbody 
formation, but results in midbody instability (Figure 1A). Remark-
ably, the same phenotype was observed with a dramatically in-
creased penetrance in proliferating cerebellar GPC cultured from 
CIT-K−/− mice, thus confirming its in vivo relevance (Figure 1B). 
Conversely, the overexpression of CIT-K may lead to the formation 
of an overstable midbody, which may result in abscission delay 
(Figure 2).
Our conclusions are fully consistent with previous loss-of-function 
experiments performed both in HeLa cells (Neumann et al., 2010) 
and in Drosophila (Naim et al., 2004).
On the basis of the available knowledge, we cannot completely 
exclude the possibility that CIT-K may act at even earlier stages, but 
we consider it quite unlikely that this may be of great physiological 
relevance. First of all, the early anillin-like cytokinesis phenotype 
obtained by overexpressing wild-type CIT-K (the present study; 
FIGURE 6: CIT-K or anillin overexpression delays abscission. (A) HeLa 
cells expressing either Cherry or CKA-Cherry were synchronized with 
the thymidine/nocodazole method, treated with vehicle or with C3 
transferase protein 2 h after release, and analyzed after one additional 
hour. Slides were then scored for the fraction of telophase cells, as 
determined by DAPI and α-tubulin staining and fluorescence 
microscopy. In every case, error bars represent SEM. Asterisks indicate 
that the difference is statistically significant using Student’s t test 
(*p < 0.05; **p < 0.01; ***p < 0.001). (B) HeLa cells were transfected 
with GFP, anillin (ANLN)-FL, or anillin-ΔNLS and analyzed as in (A).
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on early cytokinesis (Eda et al., 2001; Yamashiro et al., 2003), but it 
is well supported by our data. Indeed, while CIT-K loss strongly af-
fects active RhoA localization and levels (Figures 3B and 7, A and B), 
the inactivation of RhoA does not affect CIT-K localization (Figure 
3C). Moreover, in cells that undergo early midbody failure with oscil-
latory movements due to CIT-K overexpression, the first abnormality 
is the formation of a CIT-K crescent, which is followed by the dis-
placement of active RhoA from the midzone (Figure 5B and Movie 
S11). Finally, the inactivation of RhoA is capable of rescuing the cy-
tokinesis delay elicited by CIT-K overexpression (Figures 6A and 
S5B).
On the other hand, our data indicate that anillin works down-
stream of CIT-K and RhoA. Indeed, its normal localization to the 
midbody is affected both by CIT-K loss and by RhoA inactivation 
(Figure 3, A–C). In addition, anillin overexpression is capable of de-
laying abscission as well as CIT-K, but this property is insensitive to 
RhoA inactivation (Figure 6B). Although the binding to RhoA is 
clearly important, the full stabilization of anillin to the midbody may 
also require an additional interaction with CIT-K. Indeed, the overex-
pression of a mutant lacking the amino-terminal nuclear localization 
domain, not involved in RhoA binding and fully functional in early 
cytokinesis (Piekny and Glotzer, 2008), but strongly contributing to 
the interaction with CIT-K (Figure 4B), is not capable of delaying 
abscission (Figure 6B).
The simplest model to reconcile our data with the previous litera-
ture is that, during anaphase, CIT-K and anillin are recruited to 
the midzone by active RhoA, independently or as a preassembled 
complex. In this phase, CIT-K may weakly contribute to stabilize the 
cleavage furrow, in concert with ROCKs and other kinases, by phos-
phorylating MLC and other substrates. However, after being con-
centrated at the midbody, CIT-K becomes essential for its stabiliza-
tion, through the stabilization of RhoA and anillin. Finally, a change 
in CIT-K activity or in its scaffolding capabilities, determined by the 
eventual fulfilling of checkpoint mechanisms, may lead to RhoA 
Figure 2) or some mutant variants of it (Madaule et al., 1998) is not 
a proof that CIT-K acts early in cytokinesis, but indicates only that it 
may dominantly interfere with early cytokinesis events. Secondly, 
although it has been suggested that CIT-K might di-phosphorylate 
MLC during furrow ingression (Yamashiro et al., 2003; Matsumura, 
2005), this concept was only based on in vitro evidence. In contrast, 
the in vivo analysis of myosin phosphorylation in CIT-K knockout 
mice revealed that, if anything, MLC phosphorylation is increased, 
rather than decreased, in the neuronal precursors of mutant mice 
(Matsumura, 2005). The accumulation of myosin at the cell equator 
during cytokinesis and its functional modulation through MLC 
phosphorylation are very robust processes, probably controlled 
through both RhoA-dependent and -independent mechanisms op-
erating in parallel (Uehara et al., 2010). Accordingly, it has been re-
ported that primary hepatocytes obtained from CIT-K knockout rats 
display remarkably normal furrow ingression, even when Rho ki-
nases (ROCKs) are inactivated by means of a specific chemical in-
hibitor (Liu et al., 2003), thus implying that other RhoA-dependent 
and -independent kinases may act in parallel with ROCKs and CIT-K 
during early cytokinesis.
How does CIT-K regulate abscission? We here provide evidence 
indicating CIT-K may stabilize the midbody, principally by prevent-
ing anillin loss through the maintenance of active RhoA. The specific 
interaction of these molecules and the “master” role of CIT-K were 
supported first of all by localization studies, indicating that anillin 
and RhoA are specifically lost from the midbody when CIT-K levels 
are reduced (Figure 3) and that they are prominently recruited by 
overexpressed CIT-K (Figure 5). Moreover, in addition to the direct 
physical interactions previously reported for CIT-K and RhoA 
(Madaule et al., 1995) and for RhoA and anillin (Piekny and Glotzer, 
2008), we found that CIT-K and anillin form a physiological complex 
during mitosis exit that is detectable by reciprocal coimmunopre-
cipitation (Figure 4). The idea that CIT-K works upstream of RhoA in 
late cytokinesis is in apparent contrast with the studies performed 
FIGURE 7: CIT-K overexpression affects RhoA activation state. (A) HeLa cells were transfected with control or with CIT-K 
siRNA and synchronized with the thymidine/nocodazole method. Three hours after nocodazole release, active RhoA 
was measured by G-LISA assay (Cytoskeleton). RhoA activation was expressed as percent activation relative to control 
siRNA (set to 100%). (B) HeLa cells were transfected with Myc, CIT- K-Myc, or the indicated Myc-CIT-K fusion constructs 
and were processed as in (A). (C) HeLa cells were transfected with control or CIT-K siRNA and synchronized with the 
thymidine/nocodazole method. Cells were lysed 3 h after nocodazole release. Cell extracts were incubated with [3H]
GDP-loaded RhoA in the presence of free GTP. After 15 min of incubation, aliquots were taken in triplicate, and the 
amount of bound [3H]GDP was measured. This parameter is inversely related to the RhoA-GEF activity. (D) Cell extracts 
prepared as in (C) were incubated with [3H]GTP-loaded RhoA in the presence of free GTP. After 15 min of incubation, 
aliquots were taken in triplicate, and the amount of bound [3H]GTP was measured. This parameter is inversely related to 
the RhoA-GAP activity. In both (C) and (D), the level of nucleotide-binding in the presence of lysis buffer was set to 
100%. In every case, error bars represent SEM. Asterisks indicate that the difference is statistically significant using 
Student’s t test (*p < 0.05; **p < 0.01; ***p < 0.001).
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(Sigma-Aldrich, St. Louis, MO), rabbit polyclonal anti–CIT-K (Di 
Cunto et al., 2000), mouse monoclonal anti–CIT-K (Transduction 
Laboratories, BD Biosciences, Franklin Lakes, NJ), rabbit poly-
clonal anti-anillin for immunofluorescence (Oegema et al., 2000), 
rabbit polyclonal anti-anillin for immunoprecipitation and Western 
blot (Bethyl Laboratories, Montgomery, TX), mouse monoclonal 
anti–cyclin B (Abcam), mouse monoclonal anti-RhoA (Santa Cruz, 
Santa Cruz, CA), goat polyclonal anti-RACGAP1 (Abcam), rabbit 
polyclonal anti–p387S-RACGAP1 (Abcam), rabbit polyclonal anti-
ECT2 (Santa Cruz), rabbit polyclonal anti–myosin IIB (Sigma), 
mouse monoclonal anti-GEF-H1 (Abcam), rabbit polyclonal anti-
p885S-GEF-H1 (Abcam), mouse monoclonal anti–Aurora B (BD 
Bio sciences), rabbit polyclonal anti–p232T-Aurora B (Rockland 
Immunochemicals, Gilbertsville, PA), and mouse monoclonal anti-
p190RhoGAP (Becton Dickinson). C3 transferase protein was ob-
tained from Cytoskeleton (Denver, CO) and used in accordance 
with the manufacturer’s instructions.
Cell culture and synchronization
HeLa cells were cultured in Roswell Park Memorial Institute medium 
(RPMI) supplemented with 10% fetal bovine serum and penicillin/
streptomycin at 37°C in 5% CO2. For synchronization, asynchronous 
cultures were supplemented with 2 mM thymidine (Sigma) and 
maintained under these conditions for 16 h, then released for 4–6 h 
in fresh complete medium supplemented with 30 μM deoxycytidine. 
After release, cells were cultured for a further 16 h in fresh complete 
medium in the presence of 50 ng/ml nocodazole (Sigma), to block 
cells at prometaphase. Finally, cells were washed twice with fresh 
medium and allowed to progress through mitosis/cytokinesis for 
the times indicated in the different figures.
For immunoprecipitation experiments, HeLa cells were syn-
chronized at the G1/S boundary with 2 mM thymidine (Sigma) for 
16 h, released in fresh complete medium supplemented with 
30 μM deoxycytidine, and harvested at the times indicated in the 
different figures.
Cerebellar cell isolation and fractionation
Cerebellar cells were purified using a modification of the procedures 
described by Wechsler-Reya and Scott (1999).
Transfection and RNAi
In this study, we used the previously described anillin and CIT-K 
double-stranded RNAs (dsRNAs; Gruneberg et al., 2006; Piekny 
and Glotzer, 2008); as a control for potential off-target effects, a non-
targeting siRNA control was used (Dharmacon, Thermo Scientific, 
Lafayette, CO). Moreover, we used a pSuper-based shRNA vector, 
which has been previously described, together with the appropriate 
control (Camera et al., 2008). HeLa cells plated on six-well plate 
were transfected using 1 μg of the required plasmid DNA and 3 μl 
Trans-IT-LT1 transfection reagent (Mirus Bio, Madison, WI), or 6.25 μl 
of the required siRNA (20 μM) and 2.5 μl Lipofectamine 2000 (Invit-
rogen, Carlsbad, CA), according to the manufacturers’ instructions.
Immunofluorescence
For the detection of RhoA, cells were fixed in 10% cold TCA for 
15 min, as previously described (Yonemura et al., 2004). Methanol 
fixation at −20°C for 2 min was used for staining RACGAP1, ECT2, 
and myosin IIB. For the detection of CIT-K, anillin, and actin, cells 
were fixed in 10% paraformaldehyde. Cells were then permeabi-
lized with 0.1% (vol/vol) Triton X-100 for 10 min, blocked for 
30 min at room temperature in blocking solution (phosphate-
buffered saline, 5% bovine serum albumin [BSA]), and incubated 
inactivation, anillin loss, and abscission. With respect to this model, 
we find it particularly suggestive that the yeast homologues of anil-
lin have been implicated in the so-called “no-cut pathway,” in which 
they act downstream of Aurora B (Norden et al., 2006). Since a sim-
ilar mechanism linking Aurora B to actin persistence has also been 
recently demonstrated in mammalian cells (Steigemann and Ger-
lich, 2009), and since Aurora B is not affected by CIT-K inactivation, 
it is conceivable that the CIT-K/RhoA/anillin pathway that we have 
here described may play a role in preventing premature abscission.
Our knockdown and the overexpression studies indicate CIT-K 
can regulate, locally and globally, the activation state of RhoA. How-
ever, the precise mechanisms by which it may do so remain to be fully 
characterized. An obvious possibility would be that CIT-K may regu-
late the localization and/or the activity of RhoA-GEF and/or RhoA-
GAP proteins. However, the data shown in Figure S3 allow us to ex-
clude most of the well-characterized mechanisms. Indeed, the total 
levels and localization of ECT2 (Yuce et al., 2005), the total levels of 
GEF-H1 and its activation state (revealed by the phosphoporylation 
of the S885 residue; Birkenfeld et al., 2007), the total levels of 
p190RhoGAP (Mikawa et al., 2008), and the total levels and localiza-
tion of RACGAP1 and its activated form (phosphorylated on S387; 
Minoshima et al., 2003) are not significantly affected by CIT-K deple-
tion. On the basis of a crude measurement of RhoA-GEF and RhoA-
GAP activities, we consider it unlikely that CIT-K may repress a GAP 
protein, since the total GAP activity of late cytokinesis cells is de-
creased, rather than increased, by CIT-K depletion. On the other 
hand, the decrease of total Rho-GEF activity produced by CIT-K inac-
tivation would be consistent with the involvement of a strong Rho-
GEF, but its identity remains to be established and its role should be 
evaluated in light of the increased GAP activity. An alternative mech-
anism by which CIT-K could increase active RhoA is through a scaf-
folding function, which could be mediated, for instance, by its RhoA-
binding domain. At first glance, this mechanism may seem less 
intuitive, because it can be argued that an interaction with CIT-K 
could prevent active RhoA from interacting with anillin and/or with 
other effector proteins responsible for midbody stability. Neverthe-
less, the fact that the RhoA-binding domain is necessary for the in-
crease of active RhoA produced by CIT-K overexpression is consistent 
with this scenario. Since it has been shown that RhoA binds CIT-K and 
Rhotekin using two distinct regions, while both regions bind ROCKs 
(Fujisawa et al., 1998), it is conceivable that RhoA and CIT-K may form 
higher-order complexes with other RhoA effector molecules. This 
could simultaneously prevent the interaction of RhoA with GAP pro-
teins and make possible the deployment of RhoA function. It will be 
very interesting to investigate these possibilities in future work.
MATERIALS AND METHODS
Molecular biology
The mammalian expression construct coding for full-length mouse 
Myc-CIT-K has been previously described (Di Cunto et al., 2003). 
The Myc-CIT-K mutant constructs were generated from full-length 
Myc-CIT-K by deleting via restriction digestions the sequences en-
coding the following amino acids: Ct (0–955), Nt (955–2055), ΔC2 
(1746–2055), ΔPHZF (1388–1588). The expression construct coding 
for CIT-K-Cherry was generated by inserting the Myc-CIT-K cDNA 
into the pm-Cherry-N1 plasmid (Clontech, Mountain View, CA). The 
GFP-ceRhoA and GFP-anillin constructs were kindly provided by A. 
Piekny (Piekny and Glotzer, 2008).
Antibodies and inhibitors
The following antibodies were used: rabbit polyclonal anti-GFP 
(Abcam, Cambridge, MA), mouse monoclonal anti–Myc 9E10 
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ther loading, the MgCl2 concentration was brought to 25 mM and 
the sample was placed on ice. An aliquot was filtered through a ni-
trocellulose membrane (0.22-mm pore size; Millipore) under vac-
uum. The filter was washed twice with 5 ml of wash buffer (50 mM 
Tris-HCl, pH 7.5, 50 mM NaCl, 20 mM MgCl2, 1 mM DTT), air-dried, 
and placed in plastic vials with 5 ml of scintillation mixture (Ultima 
Gold; PerkinElmer). Bound radioactivity was measured by using a 
scintillation counter and considered as total GTP-loaded RhoA 
(100%). For GAP-activity measurements, HeLa cells were lysed in 
100 μl of a buffer containing 25 mM Tris-HCl (pH 7.5), 1% Nonidet 
P-40, 100 mM NaCl, 1% glycerol, 10 mM MgCl2, 1 mM PMSF, 1 mM 
Na3VO4, and protease inhibitors (Roche). Lysates were clarified by 
centrifugation (12,500 × g, 10 min), and 700 μg of protein extract 
were incubated in 100 μl of GAP buffer (25 mM Tris-HCl, pH 7.5, 1 
mM DTT, 1 mg/ml BSA, 2 mM GTP, 100 mM NaCl, 11 mM MgCl2) 
for 5 min at room temperature. To start the reaction, 130 μl of [γ-32P]
GTP-loaded recombinant RhoA was added, and samples were incu-
bated for 5 min at 24°C under shaking. The reaction was stopped by 
adding 5 ml of ice-cold wash buffer. Samples were filtered through 
nitrocellulose membranes, washed, and counted as described 
above; remaining RhoA-GTP was expressed as a percentage of total 
GTP-loaded RhoA.
for 1 h with the primary antibodies. Primary antibodies were de-
tected with anti–rabbit Alexa Fluor 488 or 568 (Molecular Probes, 
Invitrogen), anti–mouse Alexa Fluor 488 or 568 antisera (Molecular 
Probes), or anti–goat 594 (Molecular Probes) used at 1:1000 dilu-
tion. Polymeric F-actin was detected with phalloidin tetramethyl-
rhodamine isothiocyanate (TRITC; Sigma). To visualize DNA, fixed 
cells were stained with 4’,6-diamidino-2-dhenylindole (DAPI; 
Sigma). Images were acquired using an ApoTome system (Zeiss, 
Germany).
Immunoprecipitation and Western blotting
For all immunoprecipitations, cells were extracted with lysis buffer 
containing 1% Triton X-100, 120 mM NaCl, 50 mM Tris-HCl (pH 7.5), 
protease inhibitors (Roche, Mannheim, Germany), and 1 mM phe-
nylmethylsulfonyl fluoride (PMSF). The extracts were then clarified 
by centrifugation. Antibodies and protein-G–Sepharose beads 
(Amersham Biosciences, Uppsala, Sweden) were added to lysates 
and incubated overnight at 4°C. Pellets were washed four times with 
lysis buffer and analyzed by SDS–PAGE.
For immunoblots, immunoprecipitates or equal amounts of pro-
teins from whole-cell lysates were resolved by reduction with SDS–
PAGE and blotted to nitrocellulose filters, which were then incu-
bated with the indicated antibodies and developed using the ECL 
System (Amersham Biosciences).
Rho activation assay
To detect GTP-RhoA during late stages of cytokinesis, we used a 
Rho G-LISA assay (Cytoskeleton), according to the manufacturer’s 
specifications.
GEF activity assay
GDP-loaded RhoA was prepared by incubating 0.5 μg affinity-puri-
fied GST-tagged Rac1 in loading buffer (25 mM Tris/HCl, pH 7.5, 
1.0 mM dithiothreitol [DTT], 100 mM NaCl, 5 mM EDTA) and 0.5 μCi 
of [3H]GDP at 30°C for 10 min; this was followed by the addition of 
20 mM MgCl2 and incubation at 30°C for 10 min.
For GEF activity measurements, cells were lysed in 100 μl of a 
buffer containing 25 mmol/l Tris-HCl (pH 7.5), 1% NP40, 100 mmol/l 
NaCl, 1% glycerol, 10 mmol/l MgCl2, 1 mmol/l PMSF, 1 mmol/l 
Na3VO4, and protease inhibitors (Roche). Lysates were clarified by 
centrifugation (12,500 × g, 10 min), and 600 μg of protein extracts 
were incubated in 200 μl of Rac1GEF buffer (25 mmol/l Tris-HCl, pH 
7.5, 1 mmol/l DTT, 1 mg/l ml BSA, 2 mmol/l GTP, 100 mmol/l NaCl, 
1 mmol/l MgCl2). To start the reaction, 100 μl of [3H]GDP-loaded 
recombinant RhoA was added. Samples were analyzed 15 min after 
incubation at 24°C under shaking. The reaction was stopped by 
adding 5 ml of ice-cold wash buffer (20 mmol/l Tris-HCl, pH7.5, 
100 mmol/l NaCl, 20 mmol/l MgCl2). Samples were filtered through 
a nitrocellulose membrane (0.22-mm pore size; Millipore, Bedford, 
MA) under vacuum. The filter was washed twice with 5 ml of wash 
buffer, air-dried, and placed in plastic vials with 5 ml of scintillation 
mixture (Ultima Gold; PerkinElmer, Waltham, MA); bound residual 
radioactivity was measured using a scintillation counter.
Relative GEF activity was represented as the reciprocal func-
tion of the residual radioactivity normalized after background 
subtraction.
GAP activity assay
For GAP activity, GTP-loaded RhoA was prepared by incubating 1 
μg of affinity-purified GST-tagged RhoA in loading buffer (25 mM 
Tris-HCl, pH 7.5, 50 mM NaCl, 0.1 mM DTT, 1 mg/ml BSA, 5 μCi of 
[γ-32P]GTP) at room temperature for 10 min. Thereafter, to block fur-
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